119 related articles for article (PubMed ID: 22045358)
21. A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics.
Narimatsu H; Sawaki H; Kuno A; Kaji H; Ito H; Ikehara Y
FEBS J; 2010 Jan; 277(1):95-105. PubMed ID: 19919546
[TBL] [Abstract][Full Text] [Related]
22. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG.
Saldova R; Royle L; Radcliffe CM; Abd Hamid UM; Evans R; Arnold JN; Banks RE; Hutson R; Harvey DJ; Antrobus R; Petrescu SM; Dwek RA; Rudd PM
Glycobiology; 2007 Dec; 17(12):1344-56. PubMed ID: 17884841
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive clinico-glycomic study of 16 colorectal cancer specimens: elucidation of aberrant glycosylation and its mechanistic causes in colorectal cancer cells.
Misonou Y; Shida K; Korekane H; Seki Y; Noura S; Ohue M; Miyamoto Y
J Proteome Res; 2009 Jun; 8(6):2990-3005. PubMed ID: 19292502
[TBL] [Abstract][Full Text] [Related]
24. On the analysis of glycomics mass spectrometry data via the regularized area under the ROC curve.
Ye J; Liu H; Kirmiz C; Lebrilla CB; Rocke DM
BMC Bioinformatics; 2007 Dec; 8():477. PubMed ID: 18076765
[TBL] [Abstract][Full Text] [Related]
25. Glycoproteomics and glycomics investigation of membrane N-glycosylproteins from human colon carcinoma cells.
Vercoutter-Edouart AS; Slomianny MC; Dekeyzer-Beseme O; Haeuw JF; Michalski JC
Proteomics; 2008 Aug; 8(16):3236-56. PubMed ID: 18651673
[TBL] [Abstract][Full Text] [Related]
26. Focused glycomic analysis of the N-linked glycan biosynthetic pathway in ovarian cancer.
Abbott KL; Nairn AV; Hall EM; Horton MB; McDonald JF; Moremen KW; Dinulescu DM; Pierce M
Proteomics; 2008 Aug; 8(16):3210-20. PubMed ID: 18690643
[TBL] [Abstract][Full Text] [Related]
27. Glycosylation of mouse and human immune cells: insights emerging from N-glycomics analyses.
Antonopoulos A; North SJ; Haslam SM; Dell A
Biochem Soc Trans; 2011 Oct; 39(5):1334-40. PubMed ID: 21936811
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation.
Arnold JN; Saldova R; Hamid UM; Rudd PM
Proteomics; 2008 Aug; 8(16):3284-93. PubMed ID: 18646009
[TBL] [Abstract][Full Text] [Related]
29. Strategy for glycoproteomics: identification of glyco-alteration using multiple glycan profiling tools.
Ito H; Kuno A; Sawaki H; Sogabe M; Ozaki H; Tanaka Y; Mizokami M; Shoda J; Angata T; Sato T; Hirabayashi J; Ikehara Y; Narimatsu H
J Proteome Res; 2009 Mar; 8(3):1358-67. PubMed ID: 19178301
[TBL] [Abstract][Full Text] [Related]
30. Status of tumor markers in epithelial ovarian cancer has there been any progress? A review.
Husseinzadeh N
Gynecol Oncol; 2011 Jan; 120(1):152-7. PubMed ID: 20934205
[TBL] [Abstract][Full Text] [Related]
31. Structural glycomics using hydrophilic interaction chromatography (HILIC) with mass spectrometry.
Wuhrer M; de Boer AR; Deelder AM
Mass Spectrom Rev; 2009; 28(2):192-206. PubMed ID: 18979527
[TBL] [Abstract][Full Text] [Related]
32. N-Glycosylation of total cellular glycoproteins from the human ovarian carcinoma SKOV3 cell line and of recombinantly expressed human erythropoietin.
Machado E; Kandzia S; Carilho R; Altevogt P; Conradt HS; Costa J
Glycobiology; 2011 Mar; 21(3):376-86. PubMed ID: 21030537
[TBL] [Abstract][Full Text] [Related]
33. Shotgun Glycomics Identifies Tumor-Associated Glycan Ligands Bound by an Ovarian Carcinoma-Specific Monoclonal Antibody.
Liau B; Tan B; Teo G; Zhang P; Choo A; Rudd PM
Sci Rep; 2017 Nov; 7(1):14489. PubMed ID: 29101385
[TBL] [Abstract][Full Text] [Related]
34. Glycan and lectin microarrays for glycomics and medicinal applications.
Katrlík J; Svitel J; Gemeiner P; Kozár T; Tkac J
Med Res Rev; 2010 Mar; 30(2):394-418. PubMed ID: 20099267
[TBL] [Abstract][Full Text] [Related]
35. Precise mapping of increased sialylation pattern and the expression of acute phase proteins accompanying murine tumor progression in BALB/c mouse by integrated sera proteomics and glycomics.
Lin SY; Chen YY; Fan YY; Lin CW; Chen ST; Wang AH; Khoo KH
J Proteome Res; 2008 Aug; 7(8):3293-303. PubMed ID: 18549263
[TBL] [Abstract][Full Text] [Related]
36. Glycosylation and cancer: moving glycomics to the forefront.
Drake RR
Adv Cancer Res; 2015; 126():1-10. PubMed ID: 25727144
[TBL] [Abstract][Full Text] [Related]
37. Quantitation by isobaric labeling: applications to glycomics.
Atwood JA; Cheng L; Alvarez-Manilla G; Warren NL; York WS; Orlando R
J Proteome Res; 2008 Jan; 7(1):367-74. PubMed ID: 18047270
[TBL] [Abstract][Full Text] [Related]
38. Clinical application of quantitative glycomics.
Peng W; Zhao J; Dong X; Banazadeh A; Huang Y; Hussien A; Mechref Y
Expert Rev Proteomics; 2018 Dec; 15(12):1007-1031. PubMed ID: 30380947
[TBL] [Abstract][Full Text] [Related]
39. Altered serum N-glycomics in chronic hepatitis B patients.
Gui HL; Gao CF; Wang H; Liu XE; Xie Q; Dewaele S; Wang L; Zhuang H; Contreras R; Libert C; Chen C
Liver Int; 2010 Feb; 30(2):259-67. PubMed ID: 19951379
[TBL] [Abstract][Full Text] [Related]
40. LC-MS/MS analysis of ovarian cancer metastasis-related proteins using a nude mouse model: 14-3-3 zeta as a candidate biomarker.
He Y; Wu X; Liu X; Yan G; Xu C
J Proteome Res; 2010 Dec; 9(12):6180-90. PubMed ID: 21028892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
